RedHill Biopharma (RDHL) Announces Positive RHB-105 Phase III Study Results for H. pylori Infection
Tweet Send to a Friend
RedHill Biopharma Ltd. (NASDAQ: RDHL) announced that the positive final results, announced in June 2015, of the first Phase III ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
